Results 91 to 100 of about 2,572,697 (149)

Challenges and Prospects in the Development of a Universal SARS-CoV-2 Vaccine. [PDF]

Vaccines (Basel)
Karczmarzyk K, Kęsik-Brodacka M.
europepmc   +1 more source

Antigenicity test

Folia Pharmacologica Japonica, 2007
openaire   +3 more sources

Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells. [PDF]

Mol Ther Oncol
Jeong JH, Seo YR, Yu SR, Lee HB, Lee HJ, Cho HJ, Kim HC, Lee YH.   +7 more
europepmc   +1 more source

A Monoclonal Antibody ELISA-Based Assay for Measuring the Potency of Candidate H5 Clade 2.3.4.4b Pandemic Influenza Vaccines. [PDF]

Influenza Other Respir Viruses
Odin M, Schmeisser F, Soto J, Weir JP.
europepmc   +1 more source

Research progress on resistance mechanisms to CAR-T cell therapy in diffuse large B-cell lymphoma. [PDF]

Front Oncol
Zhang S, Liu J, Li Z.
europepmc   +1 more source

Advances and challenges of chimeric antigen receptor T cell therapy in digestive system malignancies. [PDF]

World J Clin Oncol
Wang C, Zhang J, Chen ZK, Wang YG, Shi M.   +4 more
europepmc   +1 more source

Future Perspectives on the Application of Systems Biology and Generative Artificial Intelligence in the Design of Immunogenic Peptides for Vaccines. [PDF]

Vaccines (Basel)
Lastra JMP, Sobrino I, Rodríguez Borges VM, de la Fuente J.   +3 more
europepmc   +1 more source

YMN-V115: a novel humanized BCMA/GPRC5D/CD3 trispecific antibody in relapsed/refractory multiple myeloma. [PDF]

J Immunother Cancer
Li J, Lu Q, Zhu Z, Wang X, Chen Y, Zhang Z, Yu Z, Wang Z, Chen Y, Xie H, Yang N, Lu H, Niu T, Nie C, Tong A, Li H.   +15 more
europepmc   +1 more source